Puregene provides you with increased crop yield and quality, resulting in higher revenue.
Puregene breeds the highest quality cannabis, guaranteeing maximum yield and a secure harvest. We provide you with a competitive advantage, ensuring your crop investment is based on extensive reliable data. Furthermore we provide a secure development pipeline of high value novel cannabinoids, fully compliant with local as well as international regulations. As a pioneer, we are redefining cannabis cultivation with our state-of-the-art and elite breeding program.
Puregene genetics increases your yield resulting in larger revenue.
Our holistic development pipeline of novel cannabinoids and varieties guarantee a high value product.
Due to greater resistance to pests and diseases your production will be secured.
Our varieties are tailored according to your needs and in compliance with your regulations.
High Swiss standards, field and market tested.
What we offer
Swiss quality and cannabis expertise with state of the art breeding technologies.
Clean Seeds and Clones
Our ever improving varieties are consistently checked via our proprietary clean stock protocols, eliminating potential diseases and providing full production potential.
Puregene’s scientists are dedicated to developing traits that matter – Non-flower pollination, disease resistance, Optimizing plant architecture for agricultural production. Our traits can be licensed, taking your varieties to the next level.
Puregene’s innovative variety development and trait discovery programs create new genetics for extraction, flower, and pharma markets. From outdoor cultivation for extraction, to controlled GMP indoor production environments for novel pharmaceuticals, Puregene has the solution.
Once a genetic is scientifically selected and meets Puregene`s high standards, it is then transferred into our propagation network for the production of seeds and clones. Our propagators are among the most established and trusted names in the industry.
Compliance and Regulation
We support our clients by working in close collaboration with local as well as federal laws and governments. Through our diligence and dedication to transparency, Puregene is the first company in the world to legally import cannabis into the United states.
Our state-of-the-art genomics, biochemistry and agronomy elite breeding program is strictly without any form of genome editing or CRISPR technologies.
WE DECIPHER THE COMPLETE DNA.
Puregene has sequenced the world’s first fully phased super-Pangenome with its partners, NRGene and ETH-Zürich. The Pangenome is the deciphered DNA of many plants. It was the world’s largest endeavor in cannabis genomics. The DNA-blueprint of cannabis is not a mystery anymore.
BREEDING THE BEST CANNABIS GENETICS.
All plant characteristics and traits, such as flavor, disease resistances, flower size, and yield, are controlled by its DNA. Puregene scientists are working tirelessly to discover where all these traits are located in the DNA of cannabis.
Unique genetics and predictable characteristics, maximizing production potential and minimizing production risk.
// Pure CBD
Available as clones, this haze variety contains many great production traits. It exhibits a refined aroma profile and a short flowering period.
// Pure CBG
Available as clones and seeds, our award-winning plant “Pure CBG” only produces CBG in its flowers, making extraction of Pure CBG easy.
// Pure Varins
Cannabinoid varins, those comprising of a C3 rather than a C5 side chain, are prized by both the retail and pharmaceutical industries.
Investing into the future of cannabis.
Puregene was the result of a joint academic project based on molecular breeding between Pure Holding AG and the ETH-Zürich, Europe‘s highest ranking research university.
Our substantial investment into improving cannabis genetics is a long-term commitment for the future of the industry, innovating and creating the best new varieties worldwide.
Stevens Senn, CEO of Pure Holding AG
We are committed to our clients by continuously bringing improved versions and chemistries of our varieties, ultimately solving the challenges the industry is facing.
Yannik Schlup, CBO of Puregene AG
IN COLLABORATION WITH